 Five-day bismuth-free triple therapy eradication Helicobacter pylori reduction duodenal ulcer relapse Previous studies eradication Helicobacter pylori significant reduction rate duodenal ulcer DU relapse aim study long-term effect bismuth-free triple therapy eradication pylori reduction DU relapse informed consent patients DU infection breath test BT study patients combination furazolidone amoxicillin metronidazole times day days addition eventual classical antiulcer agents attending physicians BT interval days pylori eradication Endoscopy BT months therapy possible recurrences Forty-eight patients trial patients negative pylori months end treatment positive Ninety-two percent patients bacteria ulcers asymptomatic symptomatic occasional pain therapy patients positive active ulcers patients symptomatic antiulcer drugs months treatment combined treatment furazolidone amoxicillin metronidazole days well-tolerated inexpensive effective therapeutic regime eradication pylori abolition DU relapse patients follow-up period months